“Our study is the first report to show molecular synergisms between bacteria, endosymbiont virus and protozoan parasite evading the human host – both with clinical association and experimental proof of causality,” said Raina Fichorova, MD, PhD, of the Brigham’s Department of…
Raina Fichorova, MD, PhD, founding director of the Brigham’s Genital Tract Biology Lab, was selected for a National Institutes of Child Health and Human Development (NICHD) grant to support research into drug metabolism in pregnant and lactating women. The project,…
Three members of the Department of Obstetrics and Gynecology were awarded a five-year grant through the National Institute of Child Health and Human Development’s Gynecologic Health and Disease Branch to establish a Harvard-wide Women’s Reproductive Health Research (WRHR) Program to promote the…
The Brigham’s Genital Tract Biology Lab, directed by Raina Fichorova, MD, PhD, distinguished chair of the Department of Obstetrics and Gynecology, earned accreditation from the College of American Pathologists (CAP) following a successful on-site inspection of the lab’s records, quality…
In the search of modifiable exposures during pregnancy that can improve birth outcomes and child health, a team of scientists from the NICHD-supported program Environmental Influences on Child Health Outcomes turn to the maternal diet. Link to YouTube
Brigham investigators find that distinct patterns of innate immunity can predict dysbiosis or infection in the female genital tract. Twitter.com/BrighamResearch PLoSONE Article: Aberrant Cervical Innate Immunity Predicts Onset of Dysbiosis and Sexually Transmitted Infections in Women of Reproductive Age
Raina Fichorova, MD, PhD: Innovative Reproductive Immunologist The Boston Lying-In laid the foundation of the Brigham as the first hospital in New England to provide a safe birthing place for women in 1832. Raina Fichorova June sunlight washes over the…
Raina Fichorova, MD, PhD, chief of the Division of Genital Tract Biology in the Department of Obstetrics and Gynecology, received a five-year, $4.1 million grant from the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) to…
Research in preclinical models suggests that recombinant molecule could act as a topical anti-HIV microbicide. A vaginal microbicide that could prevent sexual transmission of HIV-1 in women has tremendous potential for saving lives and helping staunch an epidemic. But the…
Raina Fichorova, MD, PhD, of the Department of Obstetrics and Gynecology, received a Small Business Innovation Research (SBIR) Grant from the National Institutes of Health (NIH) for the development of Sage Gel, a biome-friendly vaginal moisturizer to relieve genitourinary menopausal…